Recently, Chun et al. showed an enrichment of transcription factor binding sites in the enhancers of genes involved in apoptosis and immune regulation in bulk tumor samples of AT/RT-MYC, such as GMEMB1/2, RAD21, IRF5/8/9, and STAT1 [48]. This evidence concerns the gene IRF5 and neoplasm.